'Hypertensive patients' presentation slideshows

Pharmacologic Prevention of Stroke

Pharmacologic Prevention of Stroke. Jonathan Raser-Schramm, MD, PhD Medical Director, Stroke Program Christiana Care Health System March 21, 2014. Disclosures. No financial relationships Will discuss off-label use of a number of antithrombotic agents. What is a stroke?.

1.07k views • 89 slides

How to recognize the different faces of Hypertension

How to recognize the different faces of Hypertension. Reena Kuriacose, MD. FACP. March 26,2012. Disclosures. No conflict of interest Not a specialist Statistical data varied. Resistant hypertension. BP above goal in spite of > 3 anti HTN meds All of these in optimal doses

684 views • 58 slides

ACE Inhibitors and Coronary Circulation

ACE Inhibitors and Coronary Circulation. Georgios I. Papaioannou, MD Hartford Hospital 6/4/2002. Objectives. Impact of ACE-Inhibitors on atherosclerotic heart disease ACE-Inhibitors and coronary microcirculation

840 views • 52 slides

Protecting patients with hypertension How to maximize patient benefit ? Pr Roland Asmar

Protecting patients with hypertension How to maximize patient benefit ? Pr Roland Asmar. Goals of Antihypertensive Treatment ESH/ESC 2007. < 140/90 mmHg. Hypertensive patients. < 130/80 mmHg. Diabetes Patient at high risk.

829 views • 51 slides

Hypertension

Hypertension . Hypertension is one of the most important preventable causes of premature morbidity and mortality. Hypertension is a major risk factor for ischaemic and haemorrhagic stroke myocardial infarction, heart failure, chronic kidney disease, cognitive decline

1.3k views • 49 slides

Diagnosing Possible Hypertension When Emergency Department Blood Pressure is High

Diagnosing Possible Hypertension When Emergency Department Blood Pressure is High. Richard W. Niska, MD, MPH, FACEP CAPT, US Public Health Service. Introduction. Emergency physicians refer to primary care specialists for follow-up of conditions identified in the emergency department (ED).

616 views • 38 slides

Prevalence of Diabetes Mellitus and Hypertension in the elderly group, in Rural community in Pune, India

12 th Global Conference of IFA at Prague May 28 th to June 1 st 2012. Prevalence of Diabetes Mellitus and Hypertension in the elderly group, in Rural community in Pune, India. Janaseva Foundation, Pune. By, Vinod Shah, M.D Spandan Patel, M.B.B.S Disha Mehta,M.B.B.S

568 views • 32 slides

418 views • 31 slides

Dr Muhammad Arshad PGR FCPS (Cardiology)

Decreasing Sleep-Time Blood Pressure Determined by Ambulatory Monitoring Reduces Cardiovascular Risk The MAPEC Study. Dr Muhammad Arshad PGR FCPS (Cardiology). Abstract.

512 views • 31 slides

Toyoaki Murohara, Takashi Muramatsu , Kunihiro Matsushita ,

Comparison between valsartan and amlodipine regarding cardiovascular morbidity and mortality in hypertensive patients with glucose intolerance: NAGOYA HEART Study. Toyoaki Murohara, Takashi Muramatsu , Kunihiro Matsushita ,

468 views • 30 slides

Peripheral Vascular Disease/Deep Vein Thrombosis

Peripheral Vascular Disease/Deep Vein Thrombosis. Presented By: Susanne Lester-Bennett & Julie Dillenbeck-Juers. Definition of Problem. Peripheral Vascular Disease (PVD): Two distinct types of PVD (arterial, and venous) . Both involve the blood vessels of the lower extremities.

1.02k views • 26 slides

Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis

404 views • 20 slides

329 views • 20 slides

Benchmarking Clinicians

355 views • 19 slides

Adrenergic antagonist sympatholytic

Adrenergic antagonist sympatholytic. By: DR.ISRAA OMAR. Adrenergic antagonist . These group of drug bind to adrenoceptors but do not trigger the usual receptor-mediated response They can be selective or non-selective so they can be classified according to their affinity to the receptors

861 views • 18 slides

HYVET Trial

HYVET Trial. The Hypertension in the Very Elderly Trial (HYVET). HYVET Trial. HYVET Trial. Presented at ACC 2008 in Chicago Presented by Dr. Nigel S. Beckett. Copyleft Clinical Trial Results. You Must Redistribute Slides. HYVET Trial: Background.

1.23k views • 11 slides

Treatment-Resistant Hypertension: Magnitude of the Problem

247 views • 6 slides

Valsartan shows no difference in the composite PEP ( cardiovascular event ) vs amlodipine and mitigate results o

Valsartan shows no difference in the composite PEP ( cardiovascular event ) vs amlodipine and mitigate results on MI and death. Matsushita K et al. The NAGOYA-Heart trial. Late-breaking clinical trial. ACC Annual Scientific session 2011. SUMMARY.

188 views • 4 slides

Better workflow helps control blood pressures

65 views • 1 slides

Traumatic Brain Injury Re-Visited: A Pictorial Review

Traumatic Brain Injury Re-Visited: A Pictorial Review. Abstract #: eEdE-70. Cedric Pluguez-Turull, MD Wilmarie Rivera, MD Stephanie Baussan , MD Jose Lara, MD Cristina Quintero-Estades, MSIV Jose A. Quintero- Estades , MSIII Sean Maldonado, MSIII Eduardo Labat , MD.

178 views • 0 slides